CVR: 44311747
BerGenBio ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2023. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Mathas Kristensen. The company is owned by BerGenBio ASA. In 2025, the company reported a gross profit of DKK 571,502 and a net result of DKK 15,687. Equity amounted to DKK 203,099.
Virksomhedens formål er at levere management- og rådgivningsydelser samt dermed forbundne aktiviteter.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
BerGenBio ApS has published its annual report for 2025. Gross profit came to DKK 571,502, and the net result was DKK 15,687.
On February 6, 2026, BerGenBio ApS entered liquidation.
As of February 4, 2026, Kevin Mathas Kristensen is registered as liquidator of BerGenBio ApS.
As of February 4, 2026, Rune Skeie has stepped down as director of BerGenBio ApS.
On February 4, 2026, BerGenBio ApS entered liquidation.
BerGenBio ApS has published its interim report for the period September 19, 2023 – December 31, 2024.
As of December 6, 2024, Martin Olin has stepped down as adm. dir. of BerGenBio ApS.
As of September 19, 2023, Martin Olin is registered as adm. dir. of BerGenBio ApS.
As of September 19, 2023, Rune Skeie is registered as director of BerGenBio ApS.
As of September 19, 2023, is registered as an owner of BerGenBio ApS with an ownership share of 100%.
BerGenBio ApS was founded on September 19, 2023.
Companies in the same industry and area
CVR 46582845
CVR 45671844
CVR 25173066
CVR 25065298
CVR 27658490
companydata.dk